Skip to main content
. 2022 Oct 15;270(2):851–863. doi: 10.1007/s00415-022-11402-6

Fig. 4.

Fig. 4

Longitudinal headache data from medically managed IIH patients with active disease (papilloedema present at enrolment), and LOESS smoothers added to show trends across the categories. a Headache frequency (days per month). b Migraine-like headache frequency (days per month). c Headache mean severity of predominant headache (0–10 numerical rating scale). d Headache Impact Test 6 (HIT6) (quality of life measure score 36–78)